跳至主要内容
临床试验/NCT07367932
NCT07367932尚未招募4 期

Crisaborole 2% Versus Tacrolimus 0.03% Ointments for the Treatment of Mild to Moderate Atopic Dermatitis: A Comparative Study

Cairo University0 个研究点目标入组 30 人开始时间: 2026年2月1日最近更新:
干预措施

试验速览

阶段
4 期
状态
尚未招募
入组人数
30
主要终点
Improvement of Investigator's Static Global Assessment score

研究概览

简要总结

This study will compare the efficacy and safety of crisaborole ointment with tacrolimus ointment, in the treatment of patients with mild-to-moderate atopic dermatitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
5 Years 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with diagnosis of AD, according to Hanifin and Rajka criteria.
  • Patients of both genders
  • Age 5-25 years
  • Baseline Investigator's Static Global Assessment (ISGA) score of mild (2) or moderate (3).

排除标准

  • Clinically infected eczema.
  • Baseline Investigator's Static Global Assessment (ISGA) score of severe (4).
  • Associated comorbidities that exacerbate pruritus.
  • Patients receiving topical treatment for AD and/or pruritus within the past 14 days and/or systemic treatment within the past month.
  • Pregnancy and lactation if in the childbearing period

研究组 & 干预措施

Crisaborole ointment

Active Comparator

干预措施: Application of crisaborole twice daily (Drug)

Tacrolimus ointment

Active Comparator

干预措施: Tacrolimus ointment in atopic dermatitis (Drug)

结局指标

主要结局

Improvement of Investigator's Static Global Assessment score

时间窗: 3 months

1. Assessment of the \*\*Investigator's Static Global Assessment\*\* scores before and after treatment with crisaborole 2% ointment. 2. Assessment of the \*\*Investigator's Static Global Assessment\*\* before and after treatment with tacrolimus 0.03% ointment. 3. Comparison of the \*\*percentage of improvement\*\* in the \*\*Investigator's Static Global Assessment\*\* between the two treatment groups.

Improvement of Eczema Area and Severity Index

时间窗: 3 months

1. Assessment of \*\*Eczema Area and Severity Index\*\* scores before and after the use of \*\*crisaborole 2% ointment\*\*. 2. Assessment of \*\*Eczema Area and Severity Index\*\* scores before and after the use of \*\*tacrolimus 0.03% ointment\*\*. 3. Comparison of the percentage of improvement in the \*\*Eczema Area and Severity Index\*\* scores between the two treatment groups

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amira Elbendary

Lecturer

Cairo University

相似试验

Comparative Study of Crisaborole vs. Tacrolimus in... | 临床试验